TODAY'S NEWS
In a proof-of-concept study, an international scie...
In a report published by Jayadevappa et al in JAMA...
A small phase I study by Smaglo et al investigatin...
New research published by Li et al in JNCCN–...
Nonmelanoma skin cancers may display an aggressive...
More News From Today 
EDITORIALS & COMMENTARY
A number of immune checkpoint inhibitors (ICIs) have been approved by the FDA...
ES is a 41-year-old transgender male who presented to medical oncology as a referral...
In secondary data analysis (SDA) studies, investigators use data collected by other researchers...
Rucaparib and niraparib are two of the newest U.S. Food and Drug Administration–approved PARP inhibitors...
Chimeric antigen receptor (CAR) T-cell therapy represents an exciting innovation in the treatment of cancer...
More Editorials & Commentary 
